TAC regimen: Difference between revisions

	WikiDoc Resources for TAC regimen
Articles
Most recent articles on TAC regimen Most cited articles on TAC regimen Review articles on TAC regimen Articles on TAC regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on TAC regimen Images of TAC regimen Photos of TAC regimen Podcasts & MP3s on TAC regimen Videos on TAC regimen
Evidence Based Medicine
Cochrane Collaboration on TAC regimen Bandolier on TAC regimen TRIP on TAC regimen
Clinical Trials
Ongoing Trials on TAC regimen at Clinical Trials.gov Trial results on TAC regimen Clinical Trials on TAC regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on TAC regimen NICE Guidance on TAC regimen NHS PRODIGY Guidance FDA on TAC regimen CDC on TAC regimen
Books
Books on TAC regimen
News
TAC regimen in the news Be alerted to news on TAC regimen News trends on TAC regimen
Commentary
Blogs on TAC regimen
Definitions
Definitions of TAC regimen
Patient Resources / Community
Patient resources on TAC regimen Discussion groups on TAC regimen Patient Handouts on TAC regimen Directions to Hospitals Treating TAC regimen Risk calculators and risk factors for TAC regimen
Healthcare Provider Resources
Symptoms of TAC regimen Causes & Risk Factors for TAC regimen Diagnostic studies for TAC regimen Treatment of TAC regimen
Continuing Medical Education (CME)
CME Programs on TAC regimen
International
TAC regimen en Espanol TAC regimen en Francais
Business
TAC regimen in the Marketplace Patents on TAC regimen
Experimental / Informatics
List of terms related to TAC regimen

VisualWikitext

Latest revision as of 17:59, 30 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:TAC; TAC Regimen; TAC regimen; Taxotere-Adriamycin-Cytoxan Regimen

Overview

TAC regimen refers to a regimen consisting of docetaxel (taxotere), doxorubicin and cyclophosphamide used in the adjuvant setting for the treatment of breast cancer.^[1]^[2]

Regimen

TDocetaxel (Taxotere)

ADoxorubicin (Adriamycin)

CCyclophosphamide

Indications

Breast cancer^[1]

References

↑ ^1.0 ^1.1 Martin M (2006). "Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): an effective adjuvant treatment for operable breast cancer". Womens Health (Lond Engl). 2 (4): 527–37. doi:10.2217/17455057.2.4.527. PMID 19803960.
↑ "NCI Thesaurus".

[pmid19803960-1] 1.0 ^1.1 Martin M (2006). "Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): an effective adjuvant treatment for operable breast cancer". Womens Health (Lond Engl). 2 (4): 527–37. doi:10.2217/17455057.2.4.527. PMID 19803960.

[2] "NCI Thesaurus".

[1]

[2]

@@ Line 4: / Line 4: @@
 {{SK}}TAC; TAC Regimen; TAC regimen; Taxotere-Adriamycin-Cytoxan Regimen
 ==Overview==
-{{PAGENAME}} refers to a regimen consisting of [[docetaxel|docetaxel (taxotere)]], [[doxorubicin]] and [[cyclophosphamide]] used in the adjuvant setting for the treatment of [[breast cancer]].<ref name="pmid19803960">{{cite journal| author=Martin M| title=Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): an effective adjuvant treatment for operable breast cancer. | journal=Womens Health (Lond Engl) | year= 2006 | volume= 2 | issue= 4 | pages= 527-37 | pmid=19803960 | doi=10.2217/17455057.2.4.527 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19803960 }} </ref>
+{{PAGENAME}} refers to a regimen consisting of [[docetaxel|docetaxel (taxotere)]], [[doxorubicin]] and [[cyclophosphamide]] used in the adjuvant setting for the treatment of [[breast cancer]].<ref name="pmid19803960">{{cite journal| author=Martin M| title=Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): an effective adjuvant treatment for operable breast cancer. | journal=Womens Health (Lond Engl) | year= 2006 | volume= 2 | issue= 4 | pages= 527-37 | pmid=19803960 | doi=10.2217/17455057.2.4.527 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19803960 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63435&ns=NCI_Thesaurus}}</ref>
 ==Regimen==
@@ Line 17: / Line 16: @@
 ==Indications==
+*[[Breast cancer]]<ref name="pmid19803960">{{cite journal| author=Martin M| title=Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): an effective adjuvant treatment for operable breast cancer. | journal=Womens Health (Lond Engl) | year= 2006 | volume= 2 | issue= 4 | pages= 527-37 | pmid=19803960 | doi=10.2217/17455057.2.4.527 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19803960 }} </ref>
-*[[Breast cancer]]<ref name="pmid19803960">{{cite journal| author=Martin M| title=Docetaxel, doxorubicin and cyclophosphamide (the TAC regimen): an effective adjuvant treatment for operable breast cancer. | journal=Womens Health (Lond Engl) | year= 2006 | volume= 2 | issue= 4 | pages= 527-37 | pmid=19803960 | doi=10.2217/17455057.2.4.527 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19803960 }} </ref>
 ==References==
 {{Reflist|2}}
 [[Category:Chemotherapy regimens]]